Hybrigenics S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALHYG.PA research report →
About the company
Hybrigenics SA is a biotechnology firm, along with its subsidiaries, headquartered in Gallargues-le-Montueux, France. The company specializes in pioneering biotechnological advancements, particularly within oncology, regenerative medicine, and anti-aging therapies. Additionally, Hybrigenics is actively involved in developing technical solutions that leverage adipose tissue cells and stem cells.
- CEO
- Léone Atayi
- IPO
- 2007
- Employees
- 17
- HQ
- Gallargues-le-Montueux, FR
Price Chart
- Market Cap
- $3.95M
- P/E
- -0.20
- P/S
- 25.21
- P/B
- -0.78
- EV/EBITDA
- -28.65
- Div Yield
- 0.00%
- Gross Margin
- -38.14%
- Op Margin
- -196.24%
- Net Margin
- -4910.49%
- ROE
- -679.52%
- ROIC
- -66.18%
- Revenue
- $383.80K · 24502.63%
- Net Income
- $-18,846,501 · -3244.13%
- EPS
- $-0.05 · -2242.86%
- Op Income
- $-753,178
- FCF YoY
- 0.00%
- 52W High
- $0.07
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.02
- Beta
- 1.08
- Avg Volume
- 1.93M
Get TickerSpark's AI analysis on ALHYG.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ALHYG.PA coverage
Recent articles, reports, and earnings notes.
No research on ALHYG.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALHYG.PA report →Similar companies
Peers in the same neighborhood.